drugset / Trial / NCT01478607

A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients

NCT01478607

Phase 3 Completed 468 enrolled Astellas Pharma Inc
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the study is to assess the safety of repeated applications of QUTENZA in reducing pain intensity in subjects who have peripheral neuropathic pain due to diabetes.

Timeline

Start
2011-11
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 179 mg Topical